Inactive Instrument

Highlights Merck & Co., Inc. Euronext Paris

Equities

MRK

US58933Y1055

Highlights

Unlock all the news: Be the first to know and act before the market!

Global markets live: Shell, UBS, Boeing, Berkshire Hathaway, Exxon...	18/06
Big tech still runs the show	18/06
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	18/06	MT
Merck Receives FDA Approval for Capvaxive, Triggers $2 Million Payment for Ligand Pharmaceuticals	18/06	MT
US FDA approves Merck's pneumococcal vaccine for adults	18/06	RE
Merck Announces U.S. FDA Approves Capvaxive (Pneumococcal 21-Valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults	18/06	CI
Merck Announces FDA Approves Merck's Keytruda (Pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma	18/06	CI
Ex-dividend day	17/06	FA
High-risk health workers can get routine Ebola vaccine, Gavi says	13/06	RE
AbbVie inks immune disorder drug licensing deal with China's FutureGen	13/06	RE
High-risk health workers can get routine Ebola vaccine, says Gavi	13/06	RE
Merck looks for next-generation opportunities in cardiometabolic drugs	11/06	RE
Merck & Co., Inc. to Seek Acquisitions	11/06	CI
Merck: promising results in melanoma treatment	03/06	CF
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial	03/06	DJ
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival	03/06	MT
Moderna & Merck Announces 3-Year Data for mRNA-4157 in Combination with KEYTRUDA (Pembrolizumab)	03/06	CI
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up	03/06	RE
Immutep, Merck Collaborate on Trial for Lung Cancer Therapy	03/06	MT
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	31/05	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Merck & Co., Inc. Euronext Paris

Equities

MRK

US58933Y1055

Highlights

Filters